Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
December 2019
EMJ Dermatology 7 [Suppl 10] 2019
IL-23 came under the spotlight during this year’s European Academy of Dermatology and Venereology (EADV) Congress in Madrid, Spain, as the subject…
6
Mins
12 Dec 2019
IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance
The symposium “IL-23 Inhibition: From Pathophysiological Jungle to Clinical Clearance” took place during the 2019 annual European Academy of Dermatology…
10
Mins
12 Dec 2019
Latest Highlights from Guselkumab in Psoriasis from EADV 2019
Guselkumab was the first monoclonal antibody targeting the p19 subunit of IL-23 (IL-23p19) to be approved for the treatment of psoriasis.
10
Mins
12 Dec 2019
Management of Moderate-to-Severe Atopic Dermatitis in the Era of Targeted Treatments
Prof Augustin opened the symposium by underlining how the management of patients with moderate-to-severe atopic dermatitis (AD) has become more dynamic…
11
Mins
12 Dec 2019
Improving Intravenous Immunoglobulin Dosing in Autoimmune Neuropathies
This symposium took place on Monday 24th June 2019, as part of the 2019 Peripheral Nerve Society (PNS) Annual Meeting in Genoa, Italy.
3
Mins
12 Dec 2019
Anticipate Your Next Move in Chronic Myeloid Leukaemia Patient Management
Treatment decisions in chronic myeloid leukaemia (CML) are complex and require the evaluation of many factors at each stage of therapy…
6
Mins
12 Dec 2019
Integrating Selective Targeted Monoclonal Antibody Therapies for Improved Outcomes in Uncontrolled Asthma
Atypical production of several Th2 cytokines, including IL-4, IL-5, and IL-13, play a central pathogenic role in multiple atopic conditions.
December 2019
European Medical Journal 4.4 2019
EMJ 4.4 is a celebration of triumphant advancements throughout an outstanding year and our spirited elves have been working hard to ensure the year goes out with a festive bang.
9
Mins
12 Dec 2019
Editor's Pick: Identifying Shared Features and Addressing Common Challenges in Clinical Trials for Chronic Inflammatory Diseases: An Overview
Chronic inflammatory diseases (CID) encompass a wide range of pathologies affecting different organs or bodily functions…
9
Mins
12 Dec 2019
Clustering by Health Professionals in Individually Randomised Controlled Trials
Researchers that individually randomised controlled trials (iRCT) assume that the observed outcomes of participants…
←
1
2
3
…
631
632
633
634
635
636
637
…
1,058
1,059
1,060
→